home / stock / srpt / srpt quote
Last: | $154.20 |
---|---|
Change Percent: | 0.19% |
Open: | $156.46 |
Close: | $154.20 |
High: | $156.7 |
Low: | $153.65 |
Volume: | 1,307,416 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$154.2 | $156.46 | $154.2 | $156.7 | $153.65 | 1,307,416 | 07-02-2024 |
$156.75 | $158 | $156.75 | $162.95 | $155.18 | 1,651,211 | 07-01-2024 |
$158 | $157.96 | $158 | $159.77 | $156 | 1,925,528 | 06-28-2024 |
$157.96 | $156.72 | $157.96 | $158.7372 | $152.74 | 1,234,772 | 06-27-2024 |
$156.91 | $155.75 | $156.91 | $157.84 | $151.2601 | 2,267,092 | 06-26-2024 |
$158.06 | $164.52 | $158.06 | $164.52 | $157.38 | 2,330,687 | 06-25-2024 |
$163.85 | $162.25 | $163.85 | $168.305 | $162 | 4,542,939 | 06-24-2024 |
$160.72 | $161.97 | $160.72 | $173.25 | $157.251 | 15,011,554 | 06-21-2024 |
$123.5 | $117.53 | $123.5 | $123.73 | $115.74 | 2,155,138 | 06-20-2024 |
$117.52 | $117.01 | $117.52 | $120.29 | $116.77 | 1,467,811 | 06-19-2024 |
$117.52 | $117.01 | $117.52 | $120.29 | $116.77 | 1,467,811 | 06-18-2024 |
$116.83 | $122.53 | $116.83 | $122.55 | $116.5 | 1,422,151 | 06-17-2024 |
$122.84 | $124.09 | $122.84 | $125.89 | $120.34 | 1,000,460 | 06-14-2024 |
$125 | $122.22 | $125 | $125.84 | $122.22 | 2,162,067 | 06-13-2024 |
$119.98 | $122.93 | $119.98 | $123.53 | $118.7 | 701,721 | 06-12-2024 |
$121.38 | $121.48 | $121.38 | $122.56 | $119.62 | 682,470 | 06-11-2024 |
$122.59 | $123.13 | $122.59 | $124.41 | $121.68 | 1,636,235 | 06-10-2024 |
$123.32 | $117.53 | $123.32 | $124.6 | $116.52 | 1,485,701 | 06-07-2024 |
$117.44 | $119.2 | $117.44 | $119.44 | $116.93 | 1,283,601 | 06-06-2024 |
$119.79 | $119.75 | $119.79 | $122.53 | $116.5 | 1,795,025 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Sarepta Therapeutics Inc. Company Name:
SRPT Stock Symbol:
NASDAQ Market:
Sarepta Therapeutics Inc. Website:
2024-06-26 10:06:00 ET When one player stumbles in a high-stakes competition, it's often to the glee of the other contenders. In mid-June, Pfizer 's (NYSE: PFE) gene-therapy candidate to treat Duchenne muscular dystrophy (DMD) didn't hit the mark in a late-stage clinical trial; it'd...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 3.2% to $126.57 on volume of 604,432,871 shares American Rebel Holdings Inc. (AREB) rose 152.5% to $0.76 on volume of 367,740,589 shares Sirius XM Holdings Inc. (SIRI) rose 1.0% to $2.93 on volume of 329...
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is one of today's top gainers. The company's shares have moved 34.64% on the day to $166.22. Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies...